Independent guide · May 2026
Quick answer
Compounded tirzepatide is a personalized formulation of the active ingredient in Mounjaro and Zepbound, prepared in a 503A licensed pharmacy under a licensed provider's prescription. It costs $146–$385 per month — typically 60–80% less than brand-name tirzepatide. It is not FDA-approved as a finished drug but is legally prescribed when made from FDA-regulated active ingredients.
Compounded tirzepatide is a personalized formulation of tirzepatide — the active ingredient in Mounjaro and Zepbound — prepared by a state-licensed compounding pharmacy under a licensed provider's prescription. It contains the same dual GLP-1 + GIP receptor agonist as the brand-name drugs.
Compounded tirzepatide contains the same active ingredient as Mounjaro and Zepbound. Effectiveness depends on dose, adherence, and individual response — all of which are provider-determined. Trial data on the molecule (not the compound specifically) shows 15–22% body-weight loss at 72 weeks at therapeutic doses.
Compounded tirzepatide costs $146–$385 per month through licensed telehealth providers in 2026. The most affordable plans typically require 3- or 6-month commitments and offer first-order pricing around $146/month. Brand-name tirzepatide (Mounjaro) costs approximately $1,069/month at retail.
Compounded tirzepatide is legal and clinically used when prepared in a 503A licensed pharmacy under provider supervision. Safety depends on the compounding pharmacy's licensure and quality control. Only use providers whose pharmacy partners are LegitScript-certified and disclose state license numbers.
Tirzepatide activates two receptors (GLP-1 and GIP) versus semaglutide's one (GLP-1), and produces about 5 percentage points more body-weight loss in clinical trials. Compounded tirzepatide is more expensive than compounded semaglutide ($146 vs $99 starting prices). Side-effect profiles are similar.
Patients with a higher BMI seeking maximum weight loss, those who plateaued on compounded semaglutide, and those who tolerated semaglutide well but want stronger appetite suppression. Tirzepatide is a stronger molecule and tends to perform better on metabolic markers in patients with prediabetes.
Compounded tirzepatide is made in a 503A licensed compounding pharmacy from FDA-regulated tirzepatide active ingredient. After receiving a prescription from a licensed telehealth provider, the pharmacy prepares the medication to the prescribed concentration and ships it as a multi-dose vial to the patient.
Tirzepatide is more sensitive to handling than semaglutide. Reputable compounding pharmacies use cold-chain shipping with temperature monitoring. The vial should arrive cold and be stored refrigerated.
Tirzepatide is a more complex molecule to source and prepare. The active ingredient costs more, and Eli Lilly's commercial supply chain creates more friction than Novo Nordisk's in compounding-pharmacy access.
Real-world pricing: compounded tirzepatide telehealth plans start around $146/month versus $99/month for compounded semaglutide. Six-month plan first-order pricing on tirzepatide can dip to $258/month effective rate, still significantly below brand-name Mounjaro's $1,069/month list.
Use the same three-check framework as for compounded semaglutide. Verify the compounding pharmacy's LegitScript certification. Verify the provider's state medical board licensure. Read independent reviews of patient experience.
Tirzepatide-specific check: ask whether the pharmacy uses cold-chain shipping with temperature monitoring. Tirzepatide degrades faster than semaglutide at room temperature. Programs that ship without insulated cold packs and tracking are higher risk.
Patients typically follow a titration schedule similar to brand-name tirzepatide: starting at 2.5 mg weekly and increasing every 4 weeks if tolerated, up to a target dose between 5 mg and 15 mg.
GI side effects are common in the first 2–4 weeks of each dose increase. The dual-receptor mechanism produces stronger appetite suppression but slightly more pronounced nausea than semaglutide for some patients. Most adapt within a few weeks.
Independently-rated telehealth providers we recommend for this medication. Sorted by editorial score.
Comprehensive GLP-1 programs with board-certified physicians and lab monitoring
Excellent
Highest-converting GLP-1 provider — $16 EPC, personalized consultations, tailored prescriptions
Excellent
Fastest-growing GLP-1 provider — oral, sublingual, and injectable options with Affirm financing
Excellent
150K+ members with 5 medication forms — injections, oral drops, lozenges, tablets, and pills
Very Good
See how compounded tirzepatide compares to compounded semaglutide, or read our head-to-head comparison.